BeOne Medicines CEO John Oyler sells shares worth $33.52 million
ONC•CEO share sales and option exercise
BeOne Medicines CEO John Oyler disclosed sales of 109,835 American Depositary Shares on July 20-21 at prices from USD 310.08 to USD 320.06.
Oyler also reported exercising share options for 441,870 ordinary shares on July 20 at an exercise price of USD 9.23.
He reported direct ownership of 4,461,518 ordinary shares following the transactions.




